| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/26/2006 | EP1683861A1 In vitro method for obtaining recombined polynucleotide sequences, sequence libraries and resulting sequences |
| 07/26/2006 | EP1683811A2 Compositions and methods for the treatment of tumors |
| 07/26/2006 | EP1683809A1 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/26/2006 | EP1683572A1 Magnetically operated absorbent and method for the production thereof |
| 07/26/2006 | EP1683571A1 Patterning method, substrate for biomolecule immobilization using the patterning method, and biochip employing the substrate |
| 07/26/2006 | EP1683065A2 Proteome epitope tags and methods of use thereof in protein modification analysis |
| 07/26/2006 | EP1683059A2 Method for visualising the adme characteristics of chemical substances |
| 07/26/2006 | EP1682929A1 Lamellar structure and optical waveguide sensor based on photoaddressable polymers |
| 07/26/2006 | EP1682907A1 Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2 |
| 07/26/2006 | EP1682906A2 Method for distinguishing aml subtypes with differents gene dosages |
| 07/26/2006 | EP1682905A2 Method for distinguishing cbf-positive aml subtypes from cbf-negative aml subtypes |
| 07/26/2006 | EP1682904A2 Method for distinguishing who classified aml subtypes |
| 07/26/2006 | EP1682903A2 Method for distinguishing aml-specific flt3 length mutations from tkd mutations |
| 07/26/2006 | EP1682902A2 Method for distinguishing mll-ptd-positive aml from other aml subtypes |
| 07/26/2006 | EP1682901A2 Method for distinguishing leukemia subtypes |
| 07/26/2006 | EP1682900A2 METHOD FOR DISTINGUISHING T(11q23)/MLL-POSITIVE LEUKEMIAS FROM T(11q23)MLL NEGATIVE LEUKEMIAS |
| 07/26/2006 | EP1682899A2 METHOD FOR DISTINGUISHING AML SUBTYPE INV(3)(q21q26)/t(3;3)(q21q26) FROM OTHER AML SUBTYPES |
| 07/26/2006 | EP1682898A2 Method for distinguishing aml subtypes with recurring genetic aberrations |
| 07/26/2006 | EP1682897A2 Method for distinguishing immunologically defined all subtypes |
| 07/26/2006 | EP1682896A2 Method for distinguishing aml subtypes with aberrant and prognostically intermediate karyotypes |
| 07/26/2006 | EP1682895A2 Method for distinguishing prognostically definable aml |
| 07/26/2006 | EP1682894A2 Methods and means relating to hepatitis b infection |
| 07/26/2006 | EP1682893A1 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 85 (gpr85) |
| 07/26/2006 | EP1682892A1 Method and device for detecting analytes |
| 07/26/2006 | EP1682891A1 Method and apparatus for detecting analyte with filter |
| 07/26/2006 | EP1682890A2 Screening assays and methods of tumor treatment |
| 07/26/2006 | EP1682889A2 Automatic analysis of cellular samples |
| 07/26/2006 | EP1682888A1 Methods relating to molding optical lenses |
| 07/26/2006 | EP1682887A1 Gas sensor with controller, and system and method for employing same |
| 07/26/2006 | EP1682886A2 System and method for sensing and analyzing gases |
| 07/26/2006 | EP1682877A2 An improved apparatus and method for trace sulfur detection using uv fluorescence |
| 07/26/2006 | EP1682870A2 Measuring soil light response |
| 07/26/2006 | EP1682866A2 Gel-shell beads with adsorbed or bound biomolecules |
| 07/26/2006 | EP1682865A2 Method of using a reference control composition for measurement of nucleated red blood cells |
| 07/26/2006 | EP1682864A2 Device for analyte measurement |
| 07/26/2006 | EP1682863A2 Soluble phospholipids for use in clotting factor assays |
| 07/26/2006 | EP1682682A2 Compositions and methods for modulating c-rel-dependent cytokine production |
| 07/26/2006 | EP1682681A2 Method of preparing nucleic acids for detection |
| 07/26/2006 | EP1682677A2 Differential enzymatic fragmentation |
| 07/26/2006 | EP1682673A2 Detection and identification of biopolymers using fluorescence quenching |
| 07/26/2006 | EP1682670A1 Folate antagonists having improved selectivity |
| 07/26/2006 | EP1682663A2 The use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases |
| 07/26/2006 | EP1682657A2 Gene |
| 07/26/2006 | EP1682579A1 Laminin-5 gamma2-binding peptides, related compositions, and use thereof |
| 07/26/2006 | EP1682578A1 Peptide-based immunization therapy for treatment of atherosclerosis |
| 07/26/2006 | EP1682577A2 Novel cell-based assays employing voltage and calcium dyes |
| 07/26/2006 | EP1682575A1 Igf-i responsive gene and use thereof |
| 07/26/2006 | EP1682574A2 The use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases |
| 07/26/2006 | EP1682573A2 The use of eukaryotic genes affecting cell cycle control or cell cycle progression for diagnosis and treatment of proliferattive diseases |
| 07/26/2006 | EP1682569A2 Cellular membrane protein assay |
| 07/26/2006 | EP1682525A2 N-sulfonylaminocarbonyl containing compounds |
| 07/26/2006 | EP1682516A2 Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets |
| 07/26/2006 | EP1682512A2 Immunohistochemical methods |
| 07/26/2006 | EP1682261A2 System and method for carrying out multiple binding reactions in an array format |
| 07/26/2006 | EP1682170A2 Compositions able to prevent neurodegenerative processes and methods of assaying the same |
| 07/26/2006 | EP1682163A1 Proteins involved in quorum sensing |
| 07/26/2006 | EP1682159A1 Immunomodulating compositions and uses therefor |
| 07/26/2006 | EP1682106A2 Modified fviii having reduced immunogenicity through mutagenesis of a2 and c2 epitopes |
| 07/26/2006 | EP1682074A2 Compositions and methods for healthy pregnancy |
| 07/26/2006 | EP1681987A2 Sample testing device with funnel collector |
| 07/26/2006 | EP1681986A2 Method for predicting the onset or change of a medical condition |
| 07/26/2006 | EP1681983A2 Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy |
| 07/26/2006 | EP1681981A2 Generation of biochemical images and methods of use |
| 07/26/2006 | EP1642129A4 Selective labeling agent for phosphoproteome analysis and phosphorylated site analysis |
| 07/26/2006 | EP1613960A4 Methods of assessing crohn's disease patient phenotype by i2, ompc and asca serologic response |
| 07/26/2006 | EP1573314A4 Transgenic mice expressing human cd20 |
| 07/26/2006 | EP1546378A4 Microarrays and method for running hybridization reaction for multiple samples on a single microarray |
| 07/26/2006 | EP1540343A4 Method for the elimination of interferences in immunochromatographic assays |
| 07/26/2006 | EP1530719B1 Method for analysing a working fluid using impedance spectroscopy |
| 07/26/2006 | EP1525456A4 Method and apparatus for measuring white blood cell count |
| 07/26/2006 | EP1481065B1 Method for detection of leptin receptor ligands |
| 07/26/2006 | EP1463947A4 Method for reducing non-specific aggregation of latex microparticles in the presence of serum or plasma |
| 07/26/2006 | EP1463830A4 Method for classification of anti-psychotic drugs |
| 07/26/2006 | EP1438573B1 Use of cuttings for real time attenuation prediction |
| 07/26/2006 | EP1420691B1 Device for quantitative analysis of respiratory gases |
| 07/26/2006 | EP1395681B1 Pharmacological applications of mitochondrial dna assays |
| 07/26/2006 | EP1390543B1 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 07/26/2006 | EP1390114A4 Apparatus with voraxial separator and analyzer |
| 07/26/2006 | EP1353687B1 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 07/26/2006 | EP1351974B1 Using viruses to detect or purify proteins |
| 07/26/2006 | EP1299720A4 Clinical method for the genetic screening of newborns using tandem mass spectrometry |
| 07/26/2006 | EP1295113B1 Non-thermosensitive medium for analysing species inside a channel |
| 07/26/2006 | EP1278889B1 Hybridisation beacon and method of rapid sequence detection and discrimination |
| 07/26/2006 | EP1272841A4 Methods and computer software products for transcriptional annotation |
| 07/26/2006 | EP1263784B1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 07/26/2006 | EP1255994A4 Urine collection cup |
| 07/26/2006 | EP1222311B1 Electrochemiluminescence helicase assay |
| 07/26/2006 | EP1212389A4 Use of ?13 c nmr spectroscopy to produce optimum fischer-tropsch diesel fuels and blend stocks |
| 07/26/2006 | EP1207760B1 Improvements in or relating to the production of animal feed |
| 07/26/2006 | EP1185869B1 Ligand-anchor conjugates for producing a biosensor layer |
| 07/26/2006 | EP1181098B1 Cartridge for conducting a chemical reaction |
| 07/26/2006 | EP1167954B1 Method and apparatus for detecting negative ions in water |
| 07/26/2006 | EP1163519B1 Protein isolation and analysis |
| 07/26/2006 | EP1161522B1 Method of isolating cd8+ cells, and related hybridoma cells, antibodies and polypeptides |
| 07/26/2006 | EP1144677B1 Immobilization of molecules on surfaces via polymer brushes |
| 07/26/2006 | EP1125130B1 Detection of acid-resistant micro-organisms in a stool |
| 07/26/2006 | EP1123406B1 cDNA SEQUENCE TRANSCRIBING A mRNA CODING FOR THE TERMINAL OXYDASE ASSOCIATED WITH CAROTENOID BIOSYNTHESIS AND USES |
| 07/26/2006 | EP1047454B1 Methods of screening compounds useful for prevention of infection or pathogenicity |
| 07/26/2006 | EP1028743B1 TREATMENT AND DIAGNOSIS OF INFERTILITY USING TGF-beta OR ACTIVIN |
| 07/26/2006 | EP1018007B1 Addressable modular recognition system, production mode and use |